A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis

Project Details

StatusActive
Effective start/end date8/04/24 → 30/06/26

Funding

  • Bristol-Myers Squibb Australia: A$60,000.00